These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26211928)
21. Rhabdoid variant of urothelial carcinoma of the urinary bladder: a case report with emphasis on immunohistochemical analysis regarding the formation of rhabdoid morphology. Tajima S Int J Clin Exp Pathol; 2015; 8(8):9638-42. PubMed ID: 26464730 [TBL] [Abstract][Full Text] [Related]
22. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Wang G; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC Hum Pathol; 2018 Sep; 79():57-65. PubMed ID: 29763719 [TBL] [Abstract][Full Text] [Related]
23. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341 [TBL] [Abstract][Full Text] [Related]
24. Pleomorphic giant cell carcinoma of the bladder: The diagnostic challenge of an unusual variant of urothelial carcinoma. Fernández de Los Reyes I; Lacarra Fernández S; Chouza Sanin M; Huarte Pérez-Alfaro P Actas Urol Esp (Engl Ed); 2022 Nov; 46(9):584-585. PubMed ID: 36257879 [No Abstract] [Full Text] [Related]
25. Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: a case report. Alexiev BA; Papadimitriou JC; Chai TC; Ramos E; Staats PN; Drachenberg CB Pathol Res Pract; 2013 Apr; 209(4):255-9. PubMed ID: 23481349 [TBL] [Abstract][Full Text] [Related]
26. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma. Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315 [TBL] [Abstract][Full Text] [Related]
27. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma. Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124 [TBL] [Abstract][Full Text] [Related]
28. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419 [TBL] [Abstract][Full Text] [Related]
29. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma. Hayashi T; Sentani K; Oue N; Anami K; Sakamoto N; Ohara S; Teishima J; Noguchi T; Nakayama H; Taniyama K; Matsubara A; Yasui W Histopathology; 2011 Oct; 59(4):710-21. PubMed ID: 22014052 [TBL] [Abstract][Full Text] [Related]
31. Primary carcinoma of renal calyx. Williams PA; Mai KT Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038 [TBL] [Abstract][Full Text] [Related]
32. Spindle and giant cell carcinoma of the urinary bladder: a clinicopathological light microscopic and immunohistochemical study. Serio G; Zampatti C; Ceppi M Br J Urol; 1995 Feb; 75(2):167-72. PubMed ID: 7850320 [TBL] [Abstract][Full Text] [Related]
33. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Wasco MJ; Daignault S; Bradley D; Shah RB Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100 [TBL] [Abstract][Full Text] [Related]
34. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
35. The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series. Satturwar S; Parwani AV; Thomas R; Bastacky S; Dhir R; Quiroga-Garza GM Pathol Res Pract; 2022 Nov; 239():154164. PubMed ID: 36242968 [TBL] [Abstract][Full Text] [Related]
36. [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases]. Gaafar A; Garmendia M; de Miguel E; Velasco V; Ugalde A; Bilbao FJ; de Petris G; López JI Actas Urol Esp; 2008 Sep; 32(8):806-10. PubMed ID: 19013979 [TBL] [Abstract][Full Text] [Related]
37. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
38. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation. Tajima S; Koda K Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854 [TBL] [Abstract][Full Text] [Related]
39. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. Shah RB; Montgomery JS; Montie JE; Kunju LP Urol Oncol; 2013 Nov; 31(8):1650-5. PubMed ID: 22608543 [TBL] [Abstract][Full Text] [Related]
40. Urothelial carcinoma involving the gynecologic tract: a morphologic and immunohistochemical study of 6 cases. Reyes MC; Park KJ; Lin O; Ioffe O; Isacson C; Soslow RA; Reuter VE; Fine SW Am J Surg Pathol; 2012 Jul; 36(7):1058-65. PubMed ID: 22510759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]